EPISODE · Mar 18, 2026 · 26 MIN
Analytics That Matter in Biosimilar Development
from Chromatography Life · host Waters Corporation
In this episode of Chromatography Life, Neil Lander and Colette Quinn, Sr. Director of Light Scattering in QC at Waters Corporation break down how the October 2025 FDA draft guidance is reshaping expectations for biosimilar development. They explore why LC and orthogonal techniques like MALS are becoming essential for demonstrating analytical similarity and reducing reliance on clinical studies. Colette also highlights how tools like Empower™ Software support data integrity, reproducibility, and faster development timelines.
NOW PLAYING
Analytics That Matter in Biosimilar Development
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m